The synergistic activity of PLK1 and PI3K inhibition combination has been recently reported in anaplastic thyroid cancer models and was likely to be due to a reducing mitotic slippage and endoreduplication [48]. This evidence concerns the gene PLK1 and thyroid gland undifferentiated (anaplastic) carcinoma.